Louisiana State Employees Retirement System’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
CIEC
LTAS
COPPSERS
CWP
AA
CNAM
CCM
Louisiana State Employees Retirement System's CPRX Position: Q2 2026 in Review
Louisiana State Employees Retirement System reduced its Catalyst Pharmaceutical (CPRX) stake by 1.6% in Q2 2026, selling an estimated $23.6K and leaving 50,400 shares worth $1.58M. The position accounts for 0.02% of the portfolio, ranked #789.
Louisiana State Employees Retirement System first reported a position in CPRX in Q3 2022 and has held it in 16 quarters since. 83 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Louisiana State Employees Retirement System held 50,400 shares of Catalyst Pharmaceutical worth $1.58M as of Q2 2026.
- Louisiana State Employees Retirement System sold 800 Catalyst Pharmaceutical shares in Q2 2026, an estimated $23.6K.
- Catalyst Pharmaceutical made up 0.02% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #789 holding.
- Louisiana State Employees Retirement System first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
- 83 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.